`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`ARGENTUM PHARMACEUTICALS LLC
`Petitioner
`
`v.
`
`RESEARCH CORPORATION TECHNOLOGIES, INC.
`Patent Owner
`
`Patent No. RE38,551
`Issue Date: Jul. 6, 2004
`Title: ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES
`
`
`Case No. IPR2016-00204
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`
`37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent No. RE 38,551
`
`Case No. IPR2016-00204
`
`Petitioner hereby updates its mandatory notices pursuant to 37 C.F.R.
`
`§ 42.8(b). No other information under § 42.8(b) has changed since Petitioner’s last
`
`updated notices.
`
`Related Matters – 37 C.F.R. § 42.8(b)(2)
`
`Within 21 days of today’s notice, Ex Parte Reexamination Control No.
`
`90/013709 was accorded a filing date of April 29, 2016. Ex Parte Reexamination
`
`Control No. 90/013709 involves claims 1-13 of U.S. Patent No. RE 38,551.
`
`Dated: May 20, 2016,
`
`By:
`
`/Matthew J. Dowd/
`Matthew J. Dowd
`Reg. No. 47,534
`ANDREWS KURTH LLP
`1350 I Street, N.W., Suite 1100
`Washington, DC 20005
`Phone: (202) 662-2701
`Fax: (202) 974-9511
`MatthewDowd@andrewskurth.com
`
`Justin W. Crotty, Ph.D.
`Reg. No. 68,937
`ANDREWS KURTH LLP
`1350 I Street, NW, Suite 1100
`Washington, DC 20005
`Phone : 202.662.3007
`Fax: 202.974.9538
`JustinCrotty@andrewskurth.com
`
`Counsel for Petitioner
`
`-2-
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Patent No. RE 38,551
`
`Case No. IPR2016-00204
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Petitioner’s
`
`Updated Mandatory Notices was served via email at the following addresses:
`
`jrobbins@cov.com
`areister@cov.com
`rlongton@cov.com
`
`By:
`
`/Matthew J. Dowd/
`Matthew J. Dowd
`Reg. No. 47,534
`ANDREWS KURTH LLP
`1350 I Street, NW
`Suite 1100
`Washington, DC 20005
`Phone: (202) 662-2701
`Fax: (202) 974-9511
`MatthewDowd@andrewskurth.com